$FLIR, which competes with $LMT and $LLL, said over the long term, the company plans to continue its organic investments, spending about 3-4% of revenue on CapEx and 8-10% of revenue on R&D. The company intends to deploy 100% of its free cash flow going forward, maintaining a dividend payout ratio of about 25-30% of net income.
$TGT's sales for 4Q16 decreased 4.3% from last year, reflecting a 1.5% decline in comparable sales combined with with the removal of pharmacy and clinic sales from this year's results. Comparable digital channel sales grew 34% and contributed 1.8 percentage points of comparable sales growth.
$TGT reported a 42.7% drop in 4Q16 earnings due to the impact of rapidly-changing consumer behavior, which drove very strong digital growth but unexpected softness in stores. Net income fell to $817MM or $1.45 per share from $1.43Bil or $2.32 per share last year. Sales declined 4.3% to $20.69Bil. Adjusted EPS decreased 4.6% to $1.45.